ELTP insider buying and SEC filings, explained
Elite Pharmaceuticals Inc. · CIK 1053369
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- OTC
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- NJ
- Fiscal year end
- Mar 31
- Former names
- ELITE PHARMACEUTICALS INC /DE/
Insider activity in the last 12 months
Bought
$26K
Insiders who bought
1
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 9, 2026 | Purchase (code P) | Barry H Dash (Director) bought 100,000 shares at $0.2598 ($26K), reported as a purchase (code P). Holdings up 3% to 3,365,555 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 19, 2026, 6:05 AM ET |
| Aug 19, 2026 | Purchase (code P) | Barry H Dash (Director) bought 30,000 shares at $0.2900 ($9K), reported as a purchase (code P). Holdings up 1% to 3,265,555 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 10, 2026 |
1 routine transaction (such as a grant, option exercise or tax withholding) is not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Nov 3, 2026, 8:13 AM ET 8-K | Executive or director change (Item 5.02) Reg FD disclosure (Item 7.01) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow ELTP in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.